How much has Intuitive Surgical stock declined in 2026?

ISRG shares have fallen about 33% since the start of 2026.

What are the reasons for Intuitive Surgical's stock decline?

Reasons include slowing revenue growth, FDA regulatory pressure, and broader market volatility.

Is the decline a buying opportunity for ISRG?

Some analysts see the drop as overdone and a potential buying opportunity, but others warn of ongoing challenges.

Intuitive Surgical Stock Drops 33% in 2026: Is It a Buy?

Intuitive Surgical (ISRG) stock has fallen about 33% since the start of 2026. This article explores the factors behind the decline and asks if it's time to buy.

Shares of Intuitive Surgical (ISRG), the leader in robotic surgery, have taken a sharp hit since the beginning of 2026, losing nearly a third of their market value. The decline comes amid growing investor concerns, raising the question: is it time to buy the dip?

Reasons for the Decline

Slowing Revenue Growth

Recent reports indicate a slowdown in revenue growth, partly due to market saturation in the U.S. and increased competition.

Regulatory Pressure

Intuitive is facing heightened scrutiny from the FDA regarding the safety of certain procedures, which could impact future approvals.

Broader Market Volatility

ISRG has been caught in a broad sell-off in tech and healthcare stocks, as investors flock to safer assets amid economic uncertainty.

Is the Decline a Buying Opportunity?

Some analysts believe the sell-off is overdone, given Intuitive's continued dominance in robotic surgery and improving margins. However, others warn that regulatory and competitive headwinds could persist in the near term.

What to Make of It

There is no one-size-fits-all answer. Long-term investors may see the decline as a chance to buy at a lower price, but they should be aware of the risks. It's advisable to watch upcoming quarterly reports and regulatory developments before making a decision.